| No. |
Proposition |
|
For |
Against |
Abstain |
| 1 |
DIRECTOR Iain Dukes, D. Phil. |
|
|
|
|
| 2 |
DIRECTOR Athena Countouriotis MD |
|
|
|
|
| 3 |
DIRECTOR Ryan Maynard |
|
|
|
|
| 4 |
DIRECTOR Wayne P. Rothbaum |
|
|
|
|
| 5 |
DIRECTOR F. G. Vogt, Ph.D., J.D. |
|
|
|
|
| 6 |
DIRECTOR Michael Weiser, MD, PhD |
|
|
|
|
| 7 |
To approve, by non-binding advisory vote, the compensation of our named executive officers. |
|
|
|
|
| 8 |
To approve, by non-binding advisory vote, the frequency of our future votes on the compensation of our named executive officers. |
|
|
|
|
| 9 |
To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. |
|
|
|
|
| 10 |
To approve an amendment to our 2020 Employee Stock Purchase Plan to increase the number of shares of the Companys common stock authorized for issuance thereunder by 1,000,000 shares. |
|
|
|
|
| 11 |
To approve an amendment to our Certificate of Incorporation, as amended, to increase the number of authorized shares of the Companys common stock from 500,000,000 shares to 650,000,000 shares. |
|
|
|
|
| 12 |
To approve an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve Proposal 6. |
|
|
|
|